Compare AEM & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AEM | ELV |
|---|---|---|
| Founded | 1953 | 1944 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.6B | 78.9B |
| IPO Year | N/A | N/A |
| Metric | AEM | ELV |
|---|---|---|
| Price | $170.80 | $331.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 16 |
| Target Price | $181.13 | ★ $392.47 |
| AVG Volume (30 Days) | ★ 2.1M | 1.5M |
| Earning Date | 10-29-2025 | 01-22-2026 |
| Dividend Yield | 0.93% | ★ 2.05% |
| EPS Growth | ★ 237.78 | N/A |
| EPS | 6.84 | ★ 24.39 |
| Revenue | $10,567,578,000.00 | ★ $194,820,000,000.00 |
| Revenue This Year | $41.21 | $13.17 |
| Revenue Next Year | $17.09 | $3.66 |
| P/E Ratio | $25.06 | ★ $13.68 |
| Revenue Growth | ★ 35.16 | 11.96 |
| 52 Week Low | $76.91 | $273.71 |
| 52 Week High | $187.50 | $458.75 |
| Indicator | AEM | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 55.88 | 53.70 |
| Support Level | $164.31 | $326.20 |
| Resistance Level | $172.04 | $341.89 |
| Average True Range (ATR) | 5.62 | 8.60 |
| MACD | 0.48 | 1.37 |
| Stochastic Oscillator | 76.69 | 71.38 |
Agnico Eagle is a gold miner with mines in Canada, Mexico, Finland, and Australia. Agnico operated just one mine, LaRonde, as recently as 2008 before bringing its other mines online in rapid succession in the following years. It merged with Kirkland Lake Gold in 2022, acquiring the Detour Lake and Macassa mines in Canada along with the high-grade, low-cost Fosterville mine in Australia. It sold around 3.4 million gold ounces in 2024 and had about 15 years of gold reserves at end 2024. Agnico Eagle is focused on increasing gold production in lower-risk jurisdictions and bought the remaining 50% of its Canadian Malartic mine along with the Wasamac project and other assets from Yamana Gold in 2023.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.